LATS2 and hepatocellular carcinoma: Recent research demonstrated that miR-183-5p can increase HCC cell proliferation by suppressing the expression of tumor suppressors (including AKAP12, DYRK2, FOXN3, FOXO1 and LATS2) (51) which is agreement with our results.